strobilanth
cusia
nee
kuntz
member
famili
acanthacea
wide
distribut
northeast
india
bangladesh
southern
china
himalayan
region
myanmar
taiwan
cusia
root
leaf
extract
use
extens
tradit
herbal
medicin
antiinflammatori
antipyret
antimicrobi
antivir
activ
cusia
root
name
nanbanlangen
chines
commonli
use
treat
infect
respiratori
viru
influenza
virus
mump
viru
sever
acut
respiratori
syndrom
sar
coronaviru
sever
bioactiv
compon
cusia
root
includ
strobilanth
aurantiamid
acet
exhibit
antivir
activ
influenza
hepat
b
viru
infect
cusia
leaf
call
dachingyeh
chines
gener
use
product
indigo
dye
indigo
natrurali
name
qing
dai
chines
display
antibacteri
antiinflammatori
antipyret
properti
cusia
leav
contain
effect
chemic
compon
antibacteri
antiinflammatori
antitumor
activ
includ
indirubin
tryptanthrin
quinazolin
betulin
indigodol
indigodol
b
strobilanthosid
phenylethanoidglycosid
notabl
indirubin
deriv
modul
influenza
virusinduc
inflamm
suggest
antivir
immunomodulatori
agent
influenza
viru
infect
exert
inhibitori
effect
vitro
enzymat
activ
sar
coronaviru
proteas
howev
antivir
capabl
cusia
leaf
extract
yet
elucid
clarifi
properti
prove
relev
respiratori
viru
infect
human
coronaviru
belong
famili
coronavirida
denot
shortli
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
envelop
viru
singlestrand
positivesens
rna
genom
nearli
kb
size
spike
protein
major
envelop
protein
specif
bind
zinc
peptidas
angiotensinconvert
enzym
identifi
receptor
pathogen
coronavirus
sarscov
formerli
known
wuhan
coronaviru
viru
preval
spring
winter
season
temper
zone
countri
primarili
associ
immunocompromis
patient
respiratori
ill
young
children
elderli
symptom
infect
includ
common
cold
rhinorrhea
cough
fever
tachypnea
obstruct
laryng
recent
induc
outbreak
sever
respiratori
diseas
longterm
care
institut
louisiana
case
patient
age
six
patient
pneumonia
hospit
three
patient
die
moreov
isol
blood
urin
stool
sampl
children
febril
ill
caus
system
ill
rural
haiti
becom
one
primari
pathogen
respiratori
viral
diseas
howev
effect
antivir
treat
infect
studi
explor
activ
exhibit
methanol
extract
cusia
leaf
major
chemic
compon
includ
indirubin
tryptanthrin
betulin
indigodol
indigodol
b
mean
cytopath
effect
cpe
viru
yield
infect
timeofadditionremov
virucid
activ
assay
provid
dr
lia
van
der
hoek
depart
medic
microbiolog
univers
amsterdam
use
antivir
assay
rhesu
monkey
kidney
epitheli
cell
cultur
modifi
eagl
medium
hyclon
supplement
uml
penicillinstreptomycin
mm
nonessenti
amino
acid
corn
mm
sodium
pyruv
fetal
bovin
serum
gibco
cell
use
amplifi
titer
antivir
assay
human
airway
cell
also
use
test
antivir
activ
indic
compon
cultur
mem
supplement
fb
powder
cusia
leaf
collect
putian
citi
fujian
provinc
china
subject
treatment
gmp
pharmaceut
factori
china
control
sheng
chang
pharmaceut
co
ltd
zhongli
district
taoyuan
citi
taiwan
powder
cusia
leaf
lot
purchas
credit
chines
medicin
research
develop
center
china
medic
univers
hospit
taiwan
describ
previou
report
extract
cusia
leaf
powder
kg
gener
four
time
methanol
extract
l
room
temperatur
chemic
compon
indirubin
tryptanthrin
botulin
indigodol
indigodol
b
separ
partit
experi
meoh
aq
purifi
use
silica
gel
chromatographi
identifi
nmr
spectroscropi
describ
previou
report
cytotox
cusia
extract
identifi
compound
cell
evalu
mtt
bromid
assay
total
cell
per
well
seed
overnight
plate
treat
cusia
extract
indic
chemic
compon
h
treatment
mtt
solut
mgml
phosphatebuff
salin
pb
ad
well
incub
h
incub
lastli
isopropanol
ad
well
dissolv
formazan
crystal
cell
well
measur
use
microelisa
reader
cell
viabil
calcul
ratio
treat
cell
mock
cell
cpe
reduct
assay
cell
per
well
grown
overnight
plate
infect
multipl
infect
moi
immedi
treat
indic
concentr
cusia
leaf
extract
purifi
compound
indirubin
tryptanthrin
betulin
indigodol
indigodol
b
imag
cpe
infect
cell
captur
use
microscop
h
incub
cpe
cell
swell
round
vacuol
eventu
detach
imag
use
microscop
vacuol
infect
cell
predomin
addit
effect
stomach
acid
inactiv
tryptanthrin
assay
tryptanthrin
incub
n
hcl
ph
min
neutral
pb
residu
activ
cpe
reduct
infect
cell
moi
evalu
viru
yield
reduct
assay
supernat
untreat
treat
infect
cell
dilut
quantifi
viru
titer
use
plaqu
assay
serial
dilut
supernat
ad
onto
monolay
cell
h
incub
enabl
attach
entri
cell
overlaid
use
agaros
mem
contain
fb
h
incub
cell
monolay
stain
naphthol
blueblack
dye
plaqu
cell
monolay
count
determin
viru
titer
viru
yield
reduct
calcul
reduc
rate
plaqu
content
treat
infect
cell
compar
untreat
infect
cell
fifti
percent
inhibitori
concentr
calcul
percentag
viru
yield
reduct
abovement
concentr
extract
activ
compound
addit
antivir
activ
activ
compound
examin
human
lung
epitheli
cell
cell
per
well
cultur
overnight
plate
infect
moi
immedi
treat
indic
concentr
activ
compound
cpe
reduct
infect
inhibit
activ
compound
enabl
evalu
h
postinfect
measur
inhibitori
activ
extract
activ
compound
replic
cell
infect
simultan
treat
extract
activ
compound
subject
assay
accord
method
cpe
reduct
assay
describ
later
cell
fix
paraformaldehyd
pb
min
quench
mm
min
permeabil
block
use
albumin
bovin
affymetrix
plu
triton
thermo
fisher
waltham
usa
h
incub
cell
react
overnight
dilut
sera
bsa
treat
dilut
alexa
fluor
antimous
igg
antibodi
bsa
h
thermo
fisher
cell
stain
dapi
min
room
temperatur
thermo
fisher
imag
analysi
stain
cell
record
use
fluoresc
microscopi
softwar
infect
repres
ratio
cell
red
fluoresc
signal
total
cell
blue
fluoresc
signal
timeofadditionremov
assay
includ
cotreatmentremov
postinfect
treatmentremov
mode
cotreatmentremov
mode
cell
infect
moi
concurr
treat
activ
compound
h
incub
mixtur
viru
compound
remov
infect
inhibit
assay
perform
subsequ
use
immunofluoresc
stain
postinfect
treatmentremov
mode
cell
subject
infect
h
treat
activ
compound
addit
h
wash
pb
remov
mixtur
viru
compound
residu
infect
mode
determin
rel
level
cell
moreov
supernat
lysat
infect
cell
mode
collect
examin
titer
extracellular
virion
use
plaqu
assay
describ
addit
rna
genom
cell
treat
mode
quantifi
use
quantit
revers
transcript
polymeras
chain
reaction
rtqpcr
total
rna
treatedinfect
cell
h
postinfect
extract
use
purelink
mini
total
rna
purif
kit
thermofish
revers
transcrib
superscript
iii
revers
transcriptas
oligo
dt
analyz
use
sybr
greenbas
real
time
pcr
primer
pair
genespecif
primer
pair
threshold
cycl
valu
ct
rna
genom
mrna
sampl
evalu
use
realtim
pcr
system
appli
biosystem
foster
ca
usa
rel
level
rna
genom
normal
mrna
calcul
papainlik
proteas
gene
encod
nucleotid
human
coronaviru
genom
genbank
access
amplifi
use
reversetranscriptas
pcr
specif
primer
pair
forward
revers
primer
contain
hindiii
restrict
site
respect
gene
clone
vector
novagen
darmstadt
germani
express
escherichia
coli
strain
induct
mm
iptg
h
recombin
purifi
histrap
kit
amersham
piscataway
nj
usa
use
supernat
bacteri
cell
sonic
mm
imidazol
buffer
centrifug
g
min
meanwhil
concentr
puriti
integr
recombin
protein
determin
use
biorad
protein
assay
reagent
sdspage
western
blot
sampl
purifi
protein
dissolv
load
buffer
without
boil
min
resolv
sdspage
gel
stain
coomassi
brilliant
blue
sigma
darmstadt
germani
protein
separ
sdspage
gel
electrophoret
transfer
nitrocellulos
paper
block
skim
milk
react
appropri
dilut
antihi
tag
monoclon
antibodi
goat
antimous
igg
antibodi
conjug
alkalin
phosphatas
h
incub
wash
thrice
tb
contain
tween
tbst
blot
develop
tnbtbcip
gibco
furthermor
vitro
transcleavag
assay
use
horseradish
peroxidas
hrp
contain
lxgg
motif
substrat
use
analyz
proteas
activ
recombin
indic
concentr
recombin
react
substrat
reagent
contain
hrp
pb
plate
h
incub
residu
hrp
activ
measur
chromogen
solut
contain
hydrogen
peroxid
rel
transcleavag
activ
recombin
calcul
without
addit
tryptanthrinmedi
inhibit
proteas
activ
recombin
subsequ
quantifi
vitro
transcleavag
assay
addit
tryptanthrin
differ
concentr
rel
inhibitori
activ
tryptanthrin
calcul
tryptanthrin
assess
whether
activ
compound
directli
affect
viral
infect
virucid
activ
pfu
incub
indic
concentr
activ
compound
h
reduc
cellbas
antivir
effect
exert
activ
compound
dilut
viruscompound
mixtur
ad
cell
monolay
plate
analyz
residu
infect
use
plaqu
assay
describ
virucid
activ
evalu
accord
reduct
percentag
infecti
virion
direct
reaction
activ
compound
compar
untreat
group
furthermor
h
incub
viruscompound
mixtur
directli
spot
onto
nitrocellulos
membran
dotblot
assay
antibodi
evalu
integr
treat
tryptanthrin
nitrocellulos
membran
block
skim
milk
trisbuff
salin
plu
tbst
h
incub
overnight
antibodi
react
hrpconjug
antimous
igg
antibodi
invitrogen
carlsbad
ca
usa
wash
tbst
immunoreact
spot
structur
protein
spike
envelop
protein
develop
ecltm
western
blot
detect
reagent
ge
healthcar
chicago
il
usa
imag
multifunct
gel
imag
system
gentaur
san
jose
ca
usa
oneway
anova
follow
scheff
posthoc
test
use
spss
spss
inc
armonk
ny
usa
use
analyz
data
three
independ
experi
p
valu
indic
statist
signific
result
methanol
extract
cusia
leaf
less
cytotox
cell
figur
tabl
activ
cusia
leaf
extract
concentr
evalu
use
cpe
reduct
viru
yield
inhibit
assay
figur
induc
observ
vacuol
cell
h
postinfect
describ
prior
report
cusia
leaf
methanol
extract
reduc
cpe
cell
concentrationdepend
manner
figur
plaqu
assay
indic
cusia
leaf
methanol
extract
exhibit
strong
inhibitori
effect
product
progeni
virion
releas
cultur
media
cell
h
postinfect
figur
valu
cusia
leaf
methanol
extract
viru
yield
cell
figur
tabl
immunofluoresc
stain
sera
reveal
cusia
leaf
methanol
extract
inhibit
posit
h
postinfect
concentrationdepend
manner
well
figur
imag
analysi
ratio
total
cell
well
indic
cusia
leaf
methanol
extract
reduc
infect
ratio
cell
figur
result
reveal
cusia
leaf
methanol
extract
exhibit
potent
antivir
activ
chemic
compon
cusia
leaf
methanol
extract
includ
indirubin
tryptanthrin
betulin
indigodol
indigodol
b
describ
prior
report
chemic
compon
concentr
studi
antivir
activ
exhibit
use
cpe
reduct
assay
figur
among
tryptanthrin
exhibit
strongest
antivir
activ
signific
reduct
cpe
cell
h
postinfect
figur
indigodol
b
concentr
rank
second
highest
term
activ
reduc
virusinduc
cpe
h
postinfect
figur
addit
tryptanthrin
indigodol
b
exhibit
low
cytotox
cell
significantli
reduc
infect
detect
immunofluoresc
stain
assay
figur
figur
tabl
notabl
indigodol
b
deriv
tryptanthrin
conjug
ethyl
group
r
configur
also
known
figur
subsequ
antivir
activ
tryptanthrin
indigodol
b
determin
use
cpe
inhibit
viru
yield
reduct
assay
figur
cpe
reduct
assay
tryptanthrin
significantli
reduc
virusinduc
cpe
cell
h
postinfect
wherea
effect
note
indigodol
b
figur
notabl
tryptanthrin
resist
stomach
juic
n
hcl
ph
activ
min
time
induc
cpe
reduct
infect
inhibit
infect
cell
well
figur
tabl
moreov
plaqu
assay
reveal
tryptanthrin
indigodol
b
exert
potent
inhibitori
effect
vitro
progeni
product
figur
wherein
valu
viru
yield
tryptanthrin
indigol
b
respect
tabl
therefor
similar
cusia
leaf
methanol
extract
tryptanthrin
indigodol
b
exhibit
low
cytotox
high
antivir
potenti
tryptanthrin
less
toxic
human
lung
epitheli
cell
indigodol
b
figur
tabl
examin
antivir
efficaci
highest
activ
compon
tryptanthrin
cell
infect
inhibitori
effect
tryptanthrin
test
cell
use
cpe
reduct
infect
inhibit
assay
figur
antivir
assay
human
lung
epitheli
cell
perform
analyz
h
postinfect
figur
tryptanthrin
inhibit
cpe
concentrationdepend
manner
figur
top
immunofluoresc
stain
indic
tryptanthrin
significantli
reduc
percentag
cell
figur
middl
bottom
markedli
reduc
infect
valu
human
lung
epitheli
cell
figur
tabl
result
confirm
tryptanthrin
exhibit
celltyp
independ
activ
valu
cell
respect
explor
whether
tryptanthrin
interfer
replic
differ
mode
timeofadditionremov
assay
perform
examin
inhibitori
effect
tryptanthrin
earli
late
stage
replic
figur
figur
infect
assay
immunofluoresc
stain
indic
tryptanthrin
directli
reduc
percentag
cell
mode
figur
c
exhibit
strong
inhibitori
effect
earli
late
stage
replic
tryptanthrin
potent
imped
late
stage
earli
stage
figur
vs
figur
tabl
plaqu
assay
tryptanthrin
markedli
reduc
product
extracellular
virion
two
mode
impli
significantli
block
viru
product
earli
late
stage
figur
addit
tryptanthrin
exhibit
higher
inhibitori
activ
product
extracellular
virion
late
stage
earli
stage
figur
b
tabl
tryptanthrin
exhibit
higher
effect
inhibitori
effect
late
stage
replic
cycl
earli
stage
thu
function
activ
possibl
target
viral
rna
polymeras
proteas
measur
timeofadditionremov
assay
vitro
transcleavag
test
rtqpcr
assay
reveal
tryptanthrin
reduc
number
rna
genom
postinfect
treatmentremov
mode
effect
cotreatmentremov
mode
figur
result
indic
tryptanthrin
possibl
reduc
transcript
action
rnadepend
rna
polymeras
viral
replic
moreov
inhibitori
effect
tryptanthrin
proteas
activ
detect
use
vitro
transcleavag
assay
figur
recombin
protein
tag
synthes
e
coli
purifi
use
immobil
metal
affin
chromatographi
sdspage
western
blot
assay
determin
puriti
integr
recombin
protein
molecular
weight
approxim
kda
figur
recombin
protein
exhibit
proteolyt
activ
substrat
hrp
concentrationdepend
manner
figur
notabl
tryptanthrin
exhibit
dosedepend
inhibit
recombin
transcleavag
hrp
figur
result
indic
antivir
activ
tryptanthrin
associ
inhibitori
action
viral
rna
genom
synthesi
activ
later
stage
vitro
replic
link
viral
infect
virion
product
determin
virucid
activ
tryptanthrin
virucid
assay
perform
preincub
hightit
tryptanthrin
h
figur
determin
residu
infect
dilut
mixtur
use
plaqu
assay
base
neglig
effect
tryptanthrin
plaqu
format
tryptanthrin
exhibit
signific
virucid
activ
concentrationdepend
manner
valu
tryptanthrin
virucid
activ
figur
tabl
subsequ
virucid
activ
indigodol
b
cusia
leaf
methanol
extract
evalu
figur
c
notabl
indigodol
b
cusia
leaf
methanol
extract
exhibit
virucid
activ
concentrationdepend
manner
valu
indigodol
b
cusia
extract
figur
c
tabl
result
indic
tryptanthrin
indigodol
b
function
critic
compon
elicit
virucid
activ
cusia
leaf
methanol
extract
moreov
dotblot
assay
use
viruscompound
mixtur
incub
use
examin
effect
tryptanthrin
surfac
protein
integr
reveal
tryptanthrin
alter
antigen
structur
structur
protein
spike
envelop
protein
associ
inactiv
viral
infect
figur
studi
first
demonstr
antivir
efficaci
cusia
leaf
methanol
extract
figur
figur
tabl
cusia
extract
significantli
reduc
progeni
viru
product
inhibit
viral
infect
notabl
tryptanthrin
indigodol
b
origin
identifi
compound
cusia
leaf
methanol
extract
highest
activ
figur
figur
figur
tabl
tryptanthrin
first
report
distinct
antivir
agent
reduc
cpe
drastic
inhibit
progeni
viru
product
concentrationdepend
manner
figur
indigodol
b
recent
identifi
cusia
leaf
methanol
extract
tryptanthrin
deriv
conjug
ethyl
group
exhibit
intens
antivir
activ
viru
yield
figur
previou
studi
reveal
sever
activ
antivir
compound
cusia
extract
herp
simplex
lupeol
influenza
viru
strobilanth
benzoxazolinon
aurantiamid
acet
moreov
denot
inhibitor
sar
coronaviru
proteas
exert
margin
inhibitori
activ
cpe
therefor
cusia
contain
sever
activ
chemic
constitu
like
tryptanthrin
indigodol
b
variou
virus
coronavirus
influenza
virus
antivir
activ
tryptanthrin
indigodol
b
first
report
studi
figur
figur
figur
figur
figur
figur
figur
tabl
tryptanthrin
indigodol
b
less
toxic
cell
tabl
previou
report
show
tryptanthrin
signific
cytotox
effect
surviv
rate
human
normal
cell
human
foreskin
fibroblast
mast
cell
tryptanthrin
exhibit
better
antivir
activ
deriv
indigodol
b
figur
figur
exhibit
potent
activ
viru
yield
reduct
cell
infect
inhibit
cell
figur
figur
tabl
therefor
tryptanthrin
inhibit
infect
cell
effect
cell
figur
figur
tabl
result
reveal
tryptanthrin
function
potent
inhibitor
celltypeindepend
antivir
activ
tryptanthrin
significantli
target
viral
enzym
like
rnadepend
rna
polymeras
involv
late
stage
replic
moder
viral
rna
genom
synthesi
progeni
viru
product
figur
figur
figur
figur
tryptanthrin
first
isol
cusia
also
extract
indigofer
plant
persicaria
tinctoria
isati
tinctoria
also
known
isati
indigotica
tryptanthrin
varieti
pharmacolog
properti
antifung
dermatophyt
antibacteri
helicobact
pylori
antiinflammatori
antitumor
leukemia
breast
colon
cancer
cell
properti
addit
tryptanthrin
display
antiangiogen
effect
improv
skin
lesion
psoriasi
regul
mapk
express
apelin
tryptanthrin
exhibit
antineuroinflammatori
action
inactiv
pathway
suppress
inflamm
addit
tryptanthrin
exert
hepatoprotect
effect
oxid
stress
activ
ampactiv
protein
kinas
mitogenactiv
protein
kinas
cell
therefor
pharmacolog
activ
improv
antivir
potenti
tryptanthrin
virus
addit
antivir
activ
tryptanthrin
demonstr
potent
virucid
activ
figur
tabl
addit
indigodol
b
cusia
leaf
methanol
extract
exhibit
effect
virucid
activ
valu
indigodol
b
cusia
extract
figur
c
tabl
therefor
tryptanthrin
indigodol
b
suggest
key
compon
cusia
leaf
methanol
extract
exert
antivir
virucid
effect
sinc
tryptanthrin
one
critic
compon
persicaria
tinctoria
isati
tinctoria
isati
indigotica
might
play
role
antivir
properti
extract
influenza
b
dengu
japanes
enceph
pseudorabi
viru
notabl
isati
tinctori
extract
exhibit
virucid
activ
japanes
enceph
viru
pseudorabi
viru
howev
tryptanthrin
identifi
antivir
compound
isati
tinctori
extract
possibl
owe
differ
separ
method
therefor
studi
necessari
elucid
antivir
activ
tryptanthrin
influenza
b
dengu
japanes
enceph
pseudorabi
viru
futur
studi
studi
indic
tryptanthrin
identifi
major
activ
compon
cusia
leaf
methanol
extract
inhibit
replic
celltypeindepend
manner
interestingli
tryptanthrin
serv
higher
antivir
activ
indigodol
b
addit
ethyl
moieti
instead
doubl
bond
tryptanthrin
reveal
doubl
bond
quinazolin
ring
tryptanthrin
skeleton
activ
contributor
prove
antivir
activ
moreov
tryptanthrin
specif
alter
antigen
structur
viral
spike
protein
inhibit
cleavag
activ
associ
virucid
activ
inhibit
postentri
stage
replic
less
interestingli
spike
protein
show
highli
conserv
sequenc
structur
similar
sarscov
link
fact
virus
receptor
usag
thu
tryptanthrin
exhibit
virucid
action
imped
postentri
replic
might
develop
one
first
hit
compound
human
coronavirus
